Cardiac Arrest during Dexmedetomidine Infusion in a Critically Ill Patient
Published on: 2017-05-23
Dexmedetomidine has increasingly been used in ICU for management of pain, agitation and delirium. Use of it in critically ill patients may be associated with improved outcome. However, dexmedetomidine therapy has also been associated with adverse cardiovascular events like hypotension, bradycardia and asystole. Diabetic patients are at risk of cardiovascular morbidity including sudden cardiac death. Here we present a case of sudden cardiac arrest during dexmedetomidine infusion in a critically ill patient with long standing diabetes mellitus and possible diabetic cardiac autonomic neuropathy.